Viscosupplementation
Summary
Osteoarthritis (OA) constitutes a growing public health burden, and is the most common cause of musculoskeletal disability around the world. Resulting from a complex interaction of biomechanical, biochemical, and genetic factors, OA develops slowly and is characterized by the degradation of the affected joint’s cartilage and bone hypertrophy. The disability is accompanied by joint pain, stiffness, and loss of range of motion. Initially treated with various therapies including physical therapy and nonsteroidal anti-inflammatory drugs (NSAIDs), advanced cases of OA have traditionally been treated surgically. However, intra-articular viscosupplementation with hyaluronic acid (HA), a high-molecular-weight glycosaminoglycan, has become an increasingly accepted therapeutic alternative to knee replacement surgery in the symptomatic management of OA over the past decade.
Click here for sample report @ http://www.wiseguyreports.com/sample-request/165899-medipoint-viscosupplementation-global-analysis-and-market-forecasts
Scope of the Report
- Outlook of sales volume, pricing trends, revenue trends with 2016 as base year and forecasts until 2023, for viscosupplementation.
- Company share analysis in 2016, for viscosupplementation.
- Market insights and competitive assessment of the key players within the viscosupplementation market.
Key Players
Anika Therapeutics
Ferring Pharmaceuticals
Fidia Farmaceutici
Sanofi
Table of Contents
1 About the Authors 2
1.1 Analysts 2
1.1.1 Jennifer Ryan, Orthopedic Analyst, Medical Devices 2
2 Table of Contents 3
2.1 List of Tables 6
2.2 List of Figures 6
3 Executive Summary 7
3.1 Overview 7
3.2 Market Dynamics 12
3.3 Key Players in the Viscosupplementation Market 13
3.4 Viscosupplementation Market Future Outlook 13
4 Introduction 15
4.1 Catalyst 15
4.2 Related Reports 15
4.3 Upcoming Related Reports 16
5 Market Outlook 17
5.1 Procedure Trends 17
5.2 Pricing Trends 22
5.3 Revenue Trends 26
5.4 Company Share Analysis 30
.Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/165899-medipoint-viscosupplementation-global-analysis-and-market-forecasts
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Summary
Osteoarthritis (OA) constitutes a growing public health burden, and is the most common cause of musculoskeletal disability around the world. Resulting from a complex interaction of biomechanical, biochemical, and genetic factors, OA develops slowly and is characterized by the degradation of the affected joint’s cartilage and bone hypertrophy. The disability is accompanied by joint pain, stiffness, and loss of range of motion. Initially treated with various therapies including physical therapy and nonsteroidal anti-inflammatory drugs (NSAIDs), advanced cases of OA have traditionally been treated surgically. However, intra-articular viscosupplementation with hyaluronic acid (HA), a high-molecular-weight glycosaminoglycan, has become an increasingly accepted therapeutic alternative to knee replacement surgery in the symptomatic management of OA over the past decade.
Click here for sample report @ http://www.wiseguyreports.com/sample-request/165899-medipoint-viscosupplementation-global-analysis-and-market-forecasts
Scope of the Report
- Outlook of sales volume, pricing trends, revenue trends with 2016 as base year and forecasts until 2023, for viscosupplementation.
- Company share analysis in 2016, for viscosupplementation.
- Market insights and competitive assessment of the key players within the viscosupplementation market.
Key Players
Anika Therapeutics
Ferring Pharmaceuticals
Fidia Farmaceutici
Sanofi
Table of Contents
1 About the Authors 2
1.1 Analysts 2
1.1.1 Jennifer Ryan, Orthopedic Analyst, Medical Devices 2
2 Table of Contents 3
2.1 List of Tables 6
2.2 List of Figures 6
3 Executive Summary 7
3.1 Overview 7
3.2 Market Dynamics 12
3.3 Key Players in the Viscosupplementation Market 13
3.4 Viscosupplementation Market Future Outlook 13
4 Introduction 15
4.1 Catalyst 15
4.2 Related Reports 15
4.3 Upcoming Related Reports 16
5 Market Outlook 17
5.1 Procedure Trends 17
5.2 Pricing Trends 22
5.3 Revenue Trends 26
5.4 Company Share Analysis 30
.Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/165899-medipoint-viscosupplementation-global-analysis-and-market-forecasts
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
No comments:
Post a Comment